Pharmacogenetics

25 registered clinical trials studyying Pharmacogenetics — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	An Evaluation of the Impact of Pharmacist Comprehensive Medication Management With Pharmacogenomic Results to NCT07373470	University of Pittsburgh	N/A
Recruiting	Pharmacogenomics-Supported Psychotropic Prescribing Trial NCT06929533	University of Manitoba	N/A
Enrolling By Invitation	An Evaluation of the Impact of Pharmacist Personalized Medication Reviews With and Without a Discussion of Pha NCT06660264	University of Pittsburgh	N/A
Unknown	Pharmacogenetics Analysis of Fentanyl Administered in Newborns NCT05805241	IRCCS Burlo Garofolo	—
Not Yet Recruiting	Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients NCT05247814	RWTH Aachen University	—
Unknown	Perioperative Pharmacogenomic Testing NCT05063838	Peter MacCallum Cancer Centre, Australia	N/A
Withdrawn	Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans NCT04893395	Auburn University	N/A
Unknown	Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction NCT05307718	Clinical Hospital Centre Zagreb	—
Recruiting	Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-con NCT04964310	The First Affiliated Hospital with Nanjing Medical University	—
Unknown	Clozapine Induced Weight Gain NCT03996356	Cwm Taf University Health Board (NHS)	—
Unknown	Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Pa NCT03258099	Cui Yimin	—
Completed	Individualized Antiretroviral Therapy NCT03385473	Hospital Italiano de Buenos Aires	N/A
Unknown	Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patie NCT03258151	Cui Yimin	—
Completed	Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Antic NCT03154489	Universidad San Jorge	N/A
Completed	Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting NCT02937545	Duke University	N/A
Unknown	Naproxen Pharmacogenetic Study (Project 1, Aim 2) NCT04449471	University of Washington	Phase 4
Completed	The Implementation of Pharmacogenomics Into Primary Care in British Columbia NCT02383290	University of British Columbia	N/A
Completed	Medication Therapy Management With Pharmacogenetic Testing NCT01970774	Duke University	N/A
Completed	Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors NCT07041112	Juan Ruano Ruiz	—
Unknown	Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal NCT01259973	Hospital Clinic of Barcelona	Phase 1
Completed	Study of Medical Treatment for Methamphetamine Addiction NCT00833443	University of California, Los Angeles	Phase 2
Completed	Bioequivalence of Rebamipide in Korean NCT00997789	Chonnam National University Hospital	N/A
Unknown	Pharmacogenomics Studies of Antidepressants NCT01204086	National Cheng-Kung University Hospital	Phase 4
Completed	Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD) NCT00757029	Hallym University Medical Center	Phase 4
Completed	A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension NCT03276598	Helsinki University Central Hospital	Phase 4